Department of Surgery, Heelkunde Friesland Group, The Netherlands.
Department of Surgery, Canisius Wilhelmina Hospital, Nijmegen, The Netherlands.
Ann Surg. 2023 Sep 1;278(3):e440-e446. doi: 10.1097/SLA.0000000000005801. Epub 2023 Jan 24.
The aim of this study was to determine if prophylactic mesh placement is an effective, safe, and cost-effective procedure to prevent parastomal hernia (PSH) formation in the long term.
A PSH is the most frequent complication after stoma formation. Prophylactic placement of a mesh has been suggested to prevent PSH, but long-term evidence to support this approach is scarce.
In this multicentre superiority trial patients undergoing the formation of a permanent colostomy were randomly assigned to either retromuscular polypropylene mesh reinforcement or conventional colostomy formation. Primary endpoint was the incidence of a PSH after 5 years. Secondary endpoints were morbidity, mortality, quality of life, and cost-effectiveness.
A total of 150 patients were randomly assigned to the mesh group (n = 72) or nonmesh group (n = 78). For the long-term follow-up, 113 patients were analyzed, and 37 patients were lost to follow-up. After a median follow-up of 60 months (interquartile range: 48.6-64.4), 49 patients developed a PSH, 20 (27.8%) in the mesh group and 29 (37.2%) in the nonmesh group ( P = 0.22; RD: -9.4%; 95% CI: -24, 5.5). The cost related to the meshing strategy was € 2.239 lower than the nonmesh strategy (95% CI: 491.18, 3985.49), and quality-adjusted life years did not differ significantly between groups ( P = 0.959; 95% CI: -0.066, 0.070).
Prophylactic mesh placement during the formation of an end-colostomy is a safe procedure but does not reduce the incidence of PSH after 5 years of follow-up. It does, however, delay the onset of PSH without a significant difference in morbidity, mortality, or quality of life, and seems to be cost-effective.
本研究旨在确定预防性放置补片是否是一种有效、安全且具有成本效益的方法,以长期预防造口旁疝(PSH)的形成。
PSH 是造口后最常见的并发症。预防性放置补片已被建议用于预防 PSH,但长期支持这种方法的证据很少。
在这项多中心优效性试验中,接受永久性结肠造口术的患者被随机分配至肌后聚丙烯补片加强组或传统结肠造口术组。主要终点是 5 年后 PSH 的发生率。次要终点为发病率、死亡率、生活质量和成本效益。
共 150 例患者被随机分配至补片组(n=72)或非补片组(n=78)。在长期随访中,对 113 例患者进行了分析,37 例患者失访。中位随访时间为 60 个月(四分位间距:48.6-64.4),49 例患者发生 PSH,补片组 20 例(27.8%),非补片组 29 例(37.2%)(P=0.22;RD:-9.4%;95%CI:-24,5.5)。补片策略的相关成本比非补片策略低 2239 欧元(95%CI:491.18,3985.49),且两组间的质量调整生命年无显著差异(P=0.959;95%CI:-0.066,0.070)。
在结肠造口术形成过程中预防性放置补片是一种安全的方法,但不能降低 5 年随访后 PSH 的发生率。然而,它会延迟 PSH 的发生,且在发病率、死亡率或生活质量方面没有显著差异,且似乎具有成本效益。